PDCD1 and neoplasm: To better differentiate between tumour-suppressing and -promoting CD8+ T-cells, CD8+ Tregs were reported to lack other classical activation markers, such as CD69, CD25, but increased expression of checkpoint inhibitory proteins, such as CTLA4, LAG3, and PD-1 [50].